Clinical trial

IMPACT: IMPact of Antimalarials on Covid-19 Infections in RAPPORT

NCT04347798

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

OTHER · Unmapped registry intervention Hydroxychloroquine/Chloroquine Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

IMPACT: IMPact of Antimalarials on Covid-19 Infections in RAPPORT

Design: OBSERVATIONAL · Status: COMPLETED · Phase: Not specified

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2020-11-01

PhaseN/A

Conditions

Covid-19 Infectionunresolved

Rheumatoid Arthritisverified · MONDO: rheumatoid arthritis

Psoriatic Arthritisverified · MONDO: psoriatic arthritis

Hydroxychloroquineunresolved

Interventions

Hydroxychloroquine/ChloroquineOTHER

Sponsors & collaborators

University of Albertalead sponsor

Mapped research locations

EdmontonAlberta, Canada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04347798 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.